Lipigon Pharmaceuticals AB
LPGO SE0015382072
ICB 2010 : Health Care / Health CareSweden 907 36
SE-AC Umeå Tvistevägen 48 C
Registration Number 556810-9077
Founded 2010
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|
| -35% | -88% | -46% | -65% |
Historical Performance 1
| 1M | 3M | 6M | 1Y | 3Y | 5Y | All Time |
|---|---|---|---|---|---|---|
| -9% | -59% | -56% | -64% | 0% | 0% | -99% |
Annual Insiders Turnover, USD 2
| 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|
| 76,352.27 | 158,292,355.20 | 24,154.34 | 31,854.37 |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 23 Insiders: 7
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Johan Living CEO |
0.20 SEK |
260,000 Bought |
51,688 SEK |
16/12/2024 | 16/12/2024 |
| Stefan Nilsson CEO |
0.19 SEK |
95,164 Bought |
18,500 SEK |
06/12/2024 | 03/12/2024 |
| Stefan Nilsson |
0.17 SEK |
342,315 Bought |
57,733 SEK |
06/12/2024 | 02/12/2024 |
| Stefan Nilsson CEO |
0.24 SEK |
313,425 Bought |
75,104 SEK |
12/09/2024 | 10/09/2024 |
| Stefan Nilsson CEO |
0.29 SEK |
136,056 Bought |
38,950 SEK |
18/06/2024 | 17/06/2024 |
| Stefan Nilsson CEO |
0.34 SEK |
300,852 Bought |
101,293 SEK |
21/04/2024 | 19/04/2024 |
| Stefan Nilsson CEO |
0.43 SEK |
311,804 Bought |
134,771 SEK |
20/12/2023 | 20/12/2023 |
| Stefan Nilsson CEO |
0.37 SEK |
182,432 Bought |
67,865 SEK |
20/07/2023 | 20/07/2023 |
| Stefan Nilsson CEO |
1.09 SEK |
40,825 Bought |
44,499 SEK |
23/01/2023 | 20/01/2023 |
| Stefan Nilsson CEO |
44,499.60 SEK |
37,083 Bought |
1,650,178,667 SEK |
28/11/2022 | 25/11/2022 |